All
Research
Education
Recherche
Enseignement
Business
Solutions
FR
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Türkçe
JA - 日本語
PL - Polski
RU - Русский
HE - עִברִית
AR - العربية
S'identifier
Department of Pediatrics
Hong-Fen Guo has not added Biography.
If you are Hong-Fen Guo and would like to personalize this page please email our Author Liaison for assistance.
Antigen-dependent CD28 signaling selectively enhances survival and proliferation in genetically modified activated human primary T lymphocytes.
The Journal of experimental medicine Aug, 1998 | Pubmed ID: 9705944
Anti-idiotypic antibody as the surrogate antigen for cloning scFv and its fusion proteins.
Hybridoma and hybridomics Dec, 2002 | Pubmed ID: 12573107
Anti-idiotypic antibody facilitates scFv chimeric immune receptor gene transduction and clonal expansion of human lymphocytes for tumor therapy.
Hybridoma and hybridomics Aug, 2003 | Pubmed ID: 14511566
Characteristics of stem cells from human neuroblastoma cell lines and in tumors.
Neoplasia (New York, N.Y.) , 2004 | Pubmed ID: 15720811
Radioimmunotargeting of human rhabdomyosarcoma using monoclonal antibody 8H9.
Cancer biotherapy & radiopharmaceuticals Oct, 2005 | Pubmed ID: 16248769
MicroRNA miR-29 modulates expression of immunoinhibitory molecule B7-H3: potential implications for immune based therapy of human solid tumors.
Cancer research Aug, 2009 | Pubmed ID: 19584290
Interstitial infusion of glioma-targeted recombinant immunotoxin 8H9scFv-PE38.
Molecular cancer therapeutics Apr, 2010 | Pubmed ID: 20371725
In silico driven redesign of a clinically relevant antibody for the treatment of GD2 positive tumors.
PloS one , 2013 | Pubmed ID: 23696816
Preclinical evaluation of multistep targeting of diasialoganglioside GD2 using an IgG-scFv bispecific antibody with high affinity for GD2 and DOTA metal complex.
Molecular cancer therapeutics Jul, 2014 | Pubmed ID: 24944121
Alteration of Electrostatic Surface Potential Enhances Affinity and Tumor Killing Properties of Anti-ganglioside GD2 Monoclonal Antibody hu3F8.
The Journal of biological chemistry May, 2015 | Pubmed ID: 25851904
A distinct gene expression signature characterizes human neuroblastoma cancer stem cells.
Stem cell research Sep, 2015 | Pubmed ID: 26342562
Humanized Affinity-matured Monoclonal Antibody 8H9 Has Potent Antitumor Activity and Binds to FG Loop of Tumor Antigen B7-H3.
The Journal of biological chemistry Dec, 2015 | Pubmed ID: 26487718
Theranostic pretargeted radioimmunotherapy of colorectal cancer xenografts in mice using picomolar affinity ⁸⁶Y- or ¹⁷⁷Lu-DOTA-Bn binding scFv C825/GPA33 IgG bispecific immunoconjugates.
European journal of nuclear medicine and molecular imaging May, 2016 | Pubmed ID: 26596724
Curative Multicycle Radioimmunotherapy Monitored by Quantitative SPECT/CT-Based Theranostics, Using Bispecific Antibody Pretargeting Strategy in Colorectal Cancer.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine Nov, 2017 | Pubmed ID: 28705917
Development of a Tetravalent Anti-GPA33/Anti-CD3 Bispecific Antibody for Colorectal Cancers.
Molecular cancer therapeutics Oct, 2018 | Pubmed ID: 30082472
Theranostic pretargeted radioimmunotherapy of internalizing solid tumor antigens in human tumor xenografts in mice: Curative treatment of HER2-positive breast carcinoma.
Theranostics , 2018 | Pubmed ID: 30429889
An -Acetylgalactosamino Dendron-Clearing Agent for High-Therapeutic-Index DOTA-Hapten Pretargeted Radioimmunotherapy.
Bioconjugate chemistry Mar, 2020 | Pubmed ID: 31891487
Interdomain spacing and spatial configuration drive the potency of IgG-[L]-scFv T cell bispecific antibodies.
Science translational medicine Mar, 2020 | Pubmed ID: 32161106
A Self-Assembling and Disassembling (SADA) Bispecific Antibody (BsAb) Platform for Curative Two-step Pretargeted Radioimmunotherapy.
Clinical cancer research : an official journal of the American Association for Cancer Research Jan, 2021 | Pubmed ID: 32958698
Alpha radioimmunotherapy using Ac-proteus-DOTA for solid tumors - safety at curative doses.
Theranostics , 2020 | Pubmed ID: 33052220
Overcoming leukemia heterogeneity by combining T cell engaging bispecific antibodies.
Journal for immunotherapy of cancer Nov, 2020 | Pubmed ID: 33239418
Potent antitumor effect of T cells armed with anti-GD2 bispecific antibody.
Pediatric blood & cancer Jul, 2021 | Pubmed ID: 33844437
T cell engaging bispecific antibodies targeting CD33 IgV and IgC domains for the treatment of acute myeloid leukemia.
Journal for immunotherapy of cancer May, 2021 | Pubmed ID: 34035113
Novel potent anti-STEAP1 bispecific antibody to redirect T cells for cancer immunotherapy.
Journal for immunotherapy of cancer Sep, 2021 | Pubmed ID: 34497115
Intraperitoneal Pretargeted Radioimmunotherapy for Colorectal Peritoneal Carcinomatosis.
Molecular cancer therapeutics Jan, 2022 | Pubmed ID: 34667111
Targeting tumor vasculature to improve antitumor activity of T cells armed ex vivo with T cell engaging bispecific antibody.
Journal for immunotherapy of cancer Mar, 2023 | Pubmed ID: 36990507
Identification of immunotherapy and radioimmunotherapy targets on desmoplastic small round cell tumors.
Frontiers in oncology , 2023 | Pubmed ID: 37091153
Memorial Sloan Kettering Cancer Center
Madelyn Espinosa-Cotton1,
Hong-Fen Guo1,
Nai-Kong V. Cheung1
1Department of Pediatrics, Memorial Sloan Kettering Cancer Center
Confidentialité
Conditions d'utilisation
Politiques
Contactez-nous
RECOMMANDER À LA BIBLIOTHÈQUE
NEWSLETTERS JoVE
JoVE Journal
Collections de méthodes
JoVE Encyclopedia of Experiments
Archives
JoVE Core
JoVE Science Education
JoVE Lab Manual
JoVE Quiz
JoVE Playlist
Auteurs
Bibliothécaires
Accès
À PROPOS DE JoVE
JoVE Sitemap
Copyright © 2025 MyJoVE Corporation. Tous droits réservés.
Nous utilisons des cookies afin d'améliorer votre expérience sur notre site web.
En continuant à utiliser notre site ou en cliquant sur le bouton ''continuer'', vous acceptez l'utilisation de cookies.
Apprendre encore plus